Sandell Investment Services’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Sandell Investment Services’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-116,270	Closed	-$1.97M	–	30
2014 Q4	$1.97M	Buy	+116,270	New	+$1.64M	1.88%	15

Sandell Investment Services's AVNR Position: Q1 2015 in Review

Sandell Investment Services sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 116,270 shares — an estimated $1.97M sold.

Sandell Investment Services first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $1.97M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Sandell Investment Services reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Sandell Investment Services sold 116,270 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.97M.
Sandell Investment Services first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Sandell Investment Services's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.97M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Sandell Investment Services's 13F filing for Q1 2015, filed 15 May 2015.